41 – 50 of 65
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
SNP array analysis of leukemic relapse samples after allogeneic hematopoietic stem cell transplantation with a sibling donor identifies meiotic recombination spots and reveals possible correlation with the breakpoints of acquired genetic aberrations.
(
- Contribution to journal › Article
-
Mark
Can tissue microarray-based analysis of protein expression predict recurrence of stage Ta bladder cancer?
(
- Contribution to journal › Article
-
Mark
The Notch and TGF-beta Signaling Pathways Contribute to the Aggressiveness of Clear Cell Renal Cell Carcinoma.
(
- Contribution to journal › Article
- 2010
-
Mark
Deletions of 16q in Wilms Tumors Localize to Blastemal-Anaplastic Cells and Are Associated with Reduced Expression of the IRXB Renal Tubulogenesis Gene Cluster.
(
- Contribution to journal › Article
-
Mark
Genetic bottlenecks and the hazardous game of population reduction in cell line based research.
(
- Contribution to journal › Article
-
Mark
Generation of trisomies in cancer cells by multipolar mitosis and incomplete cytokinesis.
(
- Contribution to journal › Article
-
Mark
Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations.
(
- Contribution to journal › Article
-
Mark
Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome.
(
- Contribution to journal › Article
- 2009
-
Mark
Relapsed Childhood High Hyperdiploid Acute Lymphoblastic Leukemia: Genome-Wide Screening Reveals the Presence of Preleukemic Ancestral Clones and the Secondary Nature of Microdeletions and RTK-RAS Mutations
(
- Contribution to journal › Published meeting abstract
-
Mark
MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31.
(
- Contribution to journal › Article